Deontics Clinical Futures

Deontics announced as a finalist at the Patient Safety Awards 2016

Deontics announced as a finalist at the Patient Safety Awards 2016

Clinically-led artificial intelligence (AI) company Deontics has been announced as a finalist at the Patient Safety Awards 2016 in the ‘Best Emerging Technology and IT’ category.

Deontics impressed judges with its pioneering AI technology which acts as a clinical ‘sat nav’ for personalised care by integrating clinical evidence-based practice at national and local level with individual patient information directly into the patient pathway in a visually effective user interface.

Its state-of- the-art computer modelling language system provides clinicians with suggestions to support and justify clinical decisions at the point-of- care, and helps to better coordinate care delivery through alerts, reminders, clinical pathways and workflow management.

The awards, now in their 8 th year, drew praise from judges on the high quality of entries. The second round of judging will take place next week, and will see experts from the Deontics team present to a panel of senior and influential figures from the health sector. The winner will be announced on 5th July 2016 at an awards ceremony, to be held in Manchester Central alongside the Patient Safety Congress.

There were over 650 submissions, of which 170 made it to the final cut, which means that there is fierce competition for these coveted awards. They are run by HSJ and Nursing Times, whose respective editors Alastair McLellan, and Jenni Middleton, said: “The projects submitted demonstrate those who are constantly innovating and overcoming challenges to put patients’ needs first.”

The announcement as an awards finalist represents another milestone in the company’s rise since in span out of the University of Oxford, University College London and Cancer Research UK just two years ago. Deontics is already delivering new pathways for large NHS trusts, has built a lung cancer system for a global pharmaceutical company, and is in commercial discussions with several leading IT companies.

Feedback from clinicians, patients and providers has highlighted the role Deontics plays in supporting safer care. The technology helps to avoid decision-making errors and ensure performance standardisation across medicine – a key recommendation in the UK’s National Information Board (NIB) framework, Personalised Health and Care 2020 (PHaC 2020). The report references the need to “drive down variations in quality and safety of care, patients’ changing needs will go unmet, people will be harmed who should have been cured, and unacceptable variations in outcomes will persist”.

Dr. Guy Wood-Gush, CEO of Deontics said: “Unwarranted variability in clinical practice is a well- known phenomenon which can lead to unnecessary deaths and patient morbidity. Being named a finalist at the Patient Safety Awards is another step in our mission to help make personalised health and care a reality.

“The NHS is going through a period of reform and there is now increasing recognition that reducing variation through consistent and configurable local pathways is a way to improve patient experience, reduce waiting times and reduce costs by preventing avoidable readmissions reducing lengths of stay and preventing error”, continued Dr. Wood-Gush.

For more information on the awards, visit: https://www.patientsafetycongress.co.uk/2016-shortlist

For more information on Deontics, visit: www.deontics.com

About Deontics

Deontics provides personalised clinical decision support software that is the result of long-term academic research in medical artificial intelligence originating at Carnegie Mellon University, and subsequently developed at the Medical Research Council, University of Oxford, University College London and Cancer Research UK.

Deontics was founded to incorporate concepts rooted in cognitive science, artificial intelligence and medical informatics into day-to- day clinical decision making in order to improve the quality of medical care in the UK and throughout the world.

Deontics provides clinically-led artificial intelligence for healthcare providers that delivers personalised clinical decision support for quality patient outcomes. A clinical ‘sat nav’ for personalised care, it integrates clinical good practice at national and local level with individual patient information directly into the patient pathway in a visually effective user interface. Use of Deontics systems throughout a network of hospitals and primary care clinicians can greatly enhance the quality of integrated care as well as the quality of individual specific clinical decisions.

Web: www.deontics.com

Twitter: @deontics

LinkedIn: search “Deontics”

Company contacts

For further information contact:
Dr. Guy Wood-Gush, CEO, Deontics Ltd.
Tel: +44 (0) 7725 333835
Email: guy.wood-gush@deontics.com

UK artificial intelligence healthcare pioneer helps fight against Ebola and other deadly viruses

UK artificial intelligence healthcare pioneer helps fight against Ebola and other deadly viruses

Advanced technology could help save lives and halt spread of disease in the UK and abroad

London – 27th May 2015 – UK artificial intelligence pioneer Deontics has developed a breakthrough approach in the treatment of Ebola and similar illnesses that could save lives and halt the spread of disease.

The current epidemic sweeping across the West African region has now killed five times more than all other known ebola outbreaks combined. And whilst cases are levelling off, the danger still remains. Several healthcare workers returned to the UK in March after exposure to the virus, and one military healthcare worker tested positive.

In response, Deontics, a medical artificial intelligence spinout of the University of Oxford, University College London and Cancer Research UK, has used its advanced software to give doctors the ability to view guidance on the best treatment possible for Ebola and other deadly viral haemorrhagic fevers (VHF) when seeing those returning to the UK from areas at risk. Deontics is now looking to extend this capability by producing tools for use by doctors on the ground to treat Ebola patients in West Africa.

“Global health issues such as Ebola are a constant threat that needs a global response, and software such as ours can have the required impact. Our technology incorporates and deploys the clinical logic of the experts in the field to help those treating patients to make the right clinical decisions that can save lives” says Dr. Guy-Wood-Gush, CEO of Deontics.

Deontics’ advanced systems put the UK’s viral haemorrhagic fever: ACDP algorithm and guidance on management of patients guidance from Public Health England and the Department of Health on how to deal with such conditions, directly onto mobile devices and relates the relevant passages to the specific patient helping busy doctors make the right clinical decisions. Doctors can use this to help them provide the highest standards of care in a systematic way, which can reduce the chance of medical errors, disease spread and death.

The guidance is also applicable to staff in hospitals, ambulances, and public health, who are all at threat of exposure to such viral diseases. Using Deontics technology they can access best practice in dealing with VHF quickly and easily at the point of care.

As well as helping tackle Ebola, Deontics software is being used in many areas of healthcare e.g. cardiovascular disease, diabetes, common cancer treatment to reduce unwarranted variability in clinical practice.

The technology is already in use in hospitals in the US and UK and Deontics expects to extend the use of its systems both in these markets and around the world.

For more information on clinical pathways and artificial intelligence for healthcare contact Guy Wood-Gush on guy.wood-gush@deontics.com or visit the Deontics website.

About Deontics
Deontics provides personalised clinical decision support software that is the result of long-term academic research in medical artificial intelligence originating at Carnegie Mellon University, and subsequently developed at the Medical Research Council, University of Oxford, University College London and Cancer Research UK.

Deontics was founded to incorporate concepts rooted in cognitive science, artificial intelligence and medical informatics into day-to-day clinical decision making in order to improve the quality of medical care in the UK and throughout the world.

Deontics provides clinically-led artificial intelligence for healthcare providers that delivers personalised clinical decision support for quality patient outcomes. A clinical ‘sat nav’ for personalised care, it integrates clinical good practice at national and local level with individual patient information directly into the patient pathway in a visually effective user interface. Use of Deontics systems throughout a network of hospitals and primary care clinicians can greatly enhance the quality of integrated care as well as the quality of individual specific clinical decisions.

Web: www.deontics.com
Twitter: @deontics
LinkedIn: search “Deontics”

Company contacts
For further information contact:
Guy Wood-Gush, CEO, Deontics Ltd.
Tel: +44 (0) 7725 333835
Email: guy.wood-gush@deontics.com

Media contacts
For further information contact:
Chris Marsom, Highland Marketing on behalf of Deontics
Tel: +44 (0) 1877 332 719
Mob: +44 (0) 7788 393 985
Email: chrism@highland-marketing.com

Deontics to support US ambition for high-value care at HIMSS 2015

Deontics to support US ambition for high-value care at HIMSS 2015

Clinically-led healthcare artificial intelligence provider Deontics is looking to build on its US activity by attending HIMSS 2015, the world’s health technology conference being held in Chicago in 12-16 April 2015.

The firm provides physicians with a state-of-the-art clinical ‘sat nav’ for personalized care, and will seek to build on its relationships with US and UK clinical providers, electronic records companies and clinical guideline writing organizations to show how it can put actionable intelligence directly into clinical workflow.

Deontics’ products support all the key principles of the Office of the National Coordinator for Health Information Technology’s Federal Health IT Strategic Plan 2015- 2020 which aims to deliver high-value health care through, in part, the creation of evidence-based tools.

Dr Guy Wood-Gush, CEO of Deontics said: “Having already worked with organizations such as a top five US pharmaceutical company, the American Association of Consultant Endocrinologists (AACE), and a top five US hospital group, we’re keen to discuss the benefits of personalized care and our experience in this field, at HIMSS 2015.

“Our technology links scientific research and evidence into everyday clinical practice, helping providers to continuously learn, improve performance and deliver more effective and efficient patient care.”

Deontics provides robust, transparent and auditable clinical performance and resource data that can support clinical performance measurement, research, medical legal investigations and pre-authorization of treatment at an individual and population level.

Its advanced clinical pathways and decision support functionality is helping to improve patient outcomes in the US and UK. Its interoperable architecture means it can help electronic health record providers realize the potential of clinical decision support quickly and effectively.

Healthcare variation and negligence claims can be minimized through relevant use of personalized, clinical guidelines and protocols. The technology is being used to tackle major health challenges such as cancer and diabetes across the globe, and has the potential to transform clinical practice.

Deontics’ technologies are the results of long-term academic research in medical artificial intelligence originating at Carnegie Mellon University, and subsequently developed at the Medical Research Council, University of Oxford, University College London and Cancer Research UK.

To arrange a discussion or meeting on the opportunities that Deontics provides, contact Guy Wood-Gush on +44 (0)7725 333835 or guy.wood-gush@deontics.com For more information visit the Deontics website.

Also available at the event, will be Deontics’ chief technology officer Dr Ioannis Chronakis (ioannis.chronakis@deontics.com; +44 7813 131443), and chief medical officer Mr Vivek Patkar (vivek.patkar@deontics.com; +44 7947329072).

Notes to editors

About Deontics:

Deontics is an Artificial Intelligence (AI) company with world-leading clinical pathway and clinical decision support technologies. Deontics’ technologies are the results of long-term academic research in medical AI originating at Carnegie Mellon University, and subsequently developed at the MRC, CRUK, Oxford and UCL. Deontics technologies were developed from first principles for clinical use incorporating concepts from cognitive psychology and computer science. Deontics can utilize descriptive and predictive analytic outputs to create prescriptive analytics solutions.

Deontics pathway and decision products render relevant, personalized evidence items from clinical guidelines and protocols at a highly granular level at the point of care and have been shown to increase compliance with clinical guidelines in practice. These products have the potential to substantially increase clinical performance standardization and patient safety both at unit level and across sites or regions effectively combating the ‘postcode lottery’. Because decision data are captured alongside outcomes and other clinical data, Deontics provides, the capability to fully ‘measure’ clinical practice and provide a benchmark for improvement.

For more information visit www.deontics.com

Deontics UK eHealth Week news alert

Deontics to promote evidence-based care at UK eHealth Week 2015

Deontics to promote evidence-based care at UK eHealth Week 2015

A university and national cancer charity spinout that provides clinically-led artificial intelligence is to showcase its state-of-the-art technology at HC2015, part of the UK eHealth Week 2015. Deontics technology delivers innovative decision-support and executable pathway solutions to improve healthcare outcomes and patient safety.
Deontics was formed to promote and help deliver evidence-based and personalised medicine as a spinout of the University of Oxford, University College London and Cancer Research UK. The firm has already built new pathways for a large US hospital group, a national US clinical guideline organisation, NHS trusts and built a lung cancer system for a top 10 US pharmaceutical company.

The Deontics’ team will be on stand 74, Olympia National Hall, London on 3rd and 4th March, where it will show how non-technical users can work with the company’s technology to design new and improved pathways that bring personalised clinical guidelines and best practice directly into clinical workflow.

Dr Guy Wood-Gush, CEO of Deontics, said: “Technology will play an increasingly vital role in patient safety, as we have seen described in the ambitions of the National Information Board to avoid “unacceptable variations” in treatments and outcomes. This ambition is achievable now – the technology is currently available to make actionable intelligence accessible at the point of care delivery”.

“We invite delegates and fellow exhibitors of UK eHealth Week to see how our clinical decision support platform can help drive out unwarranted variability in clinical practice across the globe.”

Deontics’ technology uses the PROforma computer language to encode clinical and other guidelines into computer readable format. This platform enables a range of applications, such as individualised treatment recommendations, quality alerts, clinical trial eligibility, audit, and care pathway management and clinical workflow.

Its clinical application integrates local, national and international best practice and guidelines with patient-level data, and then presents outputs such as treatment recommendations to clinicians through a web-based user interface.

Deontics provides clinically-led artificial intelligence technology that can support future models of care with the ability to help clinicians and others design, implement and monitor new and existing care pathways without the need to know computer code.

About UK eHealth Week
UK eHealth Week, which is one of the biggest eHealth events in the UK and free for NHS staff to attend, is hosted by two large organisations for eHealth: BCS and HIMSS. The week-long event includes the HC2015 conference which takes place in Olympia’s National Hall in London on the 3rd and 4th March 2015.

The event will bring together many important figures from the healthcare industry, providing a forum for networking and discussions around all aspects of eHealth. It features speakers such as Jeremy Hunt, the Secretary of State for Health; Tim Kelsey national director for patients and information; Beverly Bryant, director of strategic systems & technology; Professor Sir Bruce Keogh national medical director; and Simon Stevens, chief executive of NHS England.

To arrange a demonstration of the solution at the event email Dr Guy Wood-Gush at guy.wood-gush@deontics.com or visit stand 74 on 3rd or 4th March.